USPTO serial 87930570
ALPHAFOLD
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Nov 17, 2020
- Examiner
- PEISECKI, MARK A
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with ALPHAFOLD?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $2,842*
Plus Government fees of $2,600
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
MOUNTAIN VIEW, CA, US
London, GB
London, GB
London, GB
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Giselle C.W. Huron
1600 Amphitheatre ParkwayMountain View, CA 94043United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical, medical and veterinary preparations, namely, pharmaceutical preparations for use on the peripheral or central nervous system for the treatment of damaged or severed nerves; pharmaceutical products for use in gene therapy; pharmaceutical preparations, namely, anti-infectives, anti-inflammatories, antibacterial pharmaceuticals, antibiotics, antifungal preparations, antivirals; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; sanitary preparations for medical purposes; biological tissue cultures for medical purposes; biological tissue cultures for veterinary purposes; biological preparations for medical and veterinary purposes, namely, biological preparations for use on the peripheral or central nervous system for the treatment of damaged or severed nerves; biological products for use in gene therapy; biological preparations, namely, anti-infectives, anti-inflammatories, antibacterial pharmaceuticals, antibiotics, antifungal preparations, antivirals; biological products for the prevention and treatment of cancer and tumors; biological preparations for the prevention and treatment of allergies; biological reagents for medical use; biological reagents for veterinary use; diagnostic preparations for medical purposes; diagnostic biomarker reagents for medical purposes; diagnostic preparations for veterinary purposes; reagents for use in medical genetic testing; reagents for use in veterinary genetic testing | ACTIVE | — |
| 009 | Downloadable Computer software, namely, software for use in designing and developing artificial intelligence, machine learning, deep learning, reinforcement learning, building neural networks, tree search, high performance computing, distributed computing, cloud computing, analytics and data mining, virtual reality, augmented reality in the field of science, chemistry, physics, biology, technology, medicine and healthcare; computer software for scientific analysis; downloadable computer modelling in the fields of science, chemistry, physics, biology; downloadable computer software in the field of biochemistry; downloadable computer software in the field of biology; downloadable computer software in the field of crystallography; downloadable computer software for solid state analysis; downloadable computer software in the field of genetics; downloadable computer software in the field of endoscopy; downloadable computer software related to biological data processing; downloadable computer software for use in determining properties or physical characteristics of organic compounds; scientific apparatus and instruments, namely, apparatus and instruments for analyzing biological material; Downloadable electronic publications the nature of newspapers, magazines, scientific journals, books, newsletters and blogs featuring artificial intelligence, machine learning, deep learning, reinforcement learning, building neural networks, tree search, high performance computing, distributed computing, cloud computing, analytics and data mining, virtual reality, augmented reality, science, chemistry, physics, biology; downloadable electronic publications in the nature of newspapers, magazines, scientific journals, books, newsletters and blogs featuring artificial intelligence, machine learning, deep learning, reinforcement learning, building neural networks, tree search, high performance computing, distributed computing, cloud computing, analytics and data mining, virtual reality, augmented reality, science, chemistry, physics, biology relating to computer modelling in the fields of science, chemistry, physics, biology; and replacement parts and fittings for all the aforesaid goods | ACTIVE | — |
| 010 | Medical or veterinary apparatus and instruments, namely, apparatus for blood analysis, medical diagnostic instruments for the analysis of body fluids, genetic testing apparatus for medical purposes; Medical apparatus for analysing properties of organic compounds; apparatus for scientific, chemical, physical, biological analysis, namely, apparatus for blood analysis, medical diagnostic instruments for the analysis of body fluids, genetic testing apparatus for medical purposes; including all the aforesaid goods for use in relation to data processing or analysis and replacement parts and fittings for all the aforesaid goods | ACTIVE | — |
| 016 | Printed matter and printed publications, namely, research papers, articles, digests, all the foregoing in the field of artificial intelligence, machine learning, deep learning, reinforcement learning, building neural networks, tree search, high performance computing, distributed computing, cloud computing, analytics and data mining, virtual reality, augmented reality, science, chemistry, physics, biology; Printed matter and printed publications, namely, research papers, articles, digests, all the foregoing relating to computer modelling of physical characteristics of organic compounds and data processing or analysis | ACTIVE | — |
| 035 | computerized data verification services, namely, verification of scientific, chemical, physical or biological data; data compilation services in the field of scientific, chemical, physical or biological analysis; compilation of information into computer databases; data processing; data analysis services in the field of scientific, chemical, physical or biological analysis; scientific, chemical, physical or biological data processing and analysis; promoting collaboration within the scientific, medical, clinical and research communities to achieve advances in those fields using artificial intelligence, machine learning, deep learning and reinforcement learning technologies; data management services, namely, management of scientific, chemical, physical or biological data; business advice, consultancy and information services in relation to the aforesaid | ACTIVE | — |
| 041 | Education, and teaching in the fields of artificial intelligence, machine learning, deep learning, reinforcement learning, building neural networks, tree search, high performance computing, distributed computing, cloud computing, analytics and data mining, virtual reality, augmented reality; science, chemistry, physics, biology; providing training in the form of seminars, webinars, conferences, classes and workshops in the field of artificial intelligence, machine learning, deep learning, reinforcement learning, building neural networks, tree search, high performance computing, distributed computing, cloud computing, analytics and data mining, virtual reality, augmented reality, science, chemistry, physics, biology; Educational services, namely, arranging, conducting and hosting events and conferences in the field of data processing or analysis; providing advisory, consultancy, and information about education relating to the foregoing | ACTIVE | — |
| 042 | scientific and technological services, namely, scientific and technical consulting, scientific research, development and design of computer software and technology in the fields of analytics and data mining, data analysis, data transformation, data visualization, statistical analysis, artificial intelligence, machine learning and virtual reality, science, chemistry, physics, biology and scientific research and new product design services provided in connection with the foregoing; Industrial research services in the field of in the field of artificial intelligence, machine learning, deep learning, reinforcement learning, building neural networks, tree search, high performance computing, distributed computing, cloud computing, analytics and data mining, virtual reality, augmented reality; science, chemistry, physics, biology; industrial analysis, in the fields of artificial intelligence, machine learning, deep learning, reinforcement learning, building neural networks, tree search, high performance computing, distributed computing, cloud computing, analytics and data mining, virtual reality, augmented reality, science, chemistry, physics, biology; design and development of computer hardware and software; computer technology consultancy; computer aided scientific analysis in the field of artificial intelligence, machine learning, deep learning, reinforcement learning, building neural networks, tree search, high performance computing, distributed computing, cloud computing, analytics and data mining, virtual reality, augmented reality, science, chemistry, physics, biology; computer modelling services; scientific research into organic compounds; scientific services for the analysis of organic compounds; crystallography services; all the aforesaid in relation to data processing or analysis; technological advice, consultancy and information services in relation to the aforesaid | ACTIVE | — |
| 044 | Medical services; veterinary services; genetic services, namely, genetic counseling, genetic testing for medical purposes, genetic testing for veterinary purposes including all the aforesaid in relation to data processing or analysis; medical advice, consultancy and information services in relation to the aforesaid | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by GOOGLE LLC
- Other trademarks owned by DeepMind Technologies Limited
- Other trademarks owned by DeepMind Technologies Limited
- Other trademarks owned by DeepMind Technologies Limited
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 016
- Other trademarks in Class 035
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named ALPHAFOLD
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 4, 2026 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Nov 17, 2025 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Mar 19, 2025 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Jul 31, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 31, 2024 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Jul 31, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 31, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Nov 17, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 1, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 1, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 12, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 24, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 23, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 23, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 17, 2020 | NREV | NOTICE OF REVIVAL - E-MAILED | — |
| Jul 17, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 17, 2020 | PETG | PETITION TO REVIVE-GRANTED | — |
| Jul 17, 2020 | PROA | TEAS PETITION TO REVIVE RECEIVED | — |
| Jun 12, 2020 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jun 12, 2020 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jun 12, 2020 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Jun 12, 2020 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 12, 2020 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jun 12, 2020 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jun 8, 2020 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jun 5, 2020 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Oct 30, 2019 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Oct 30, 2019 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Oct 30, 2019 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Oct 4, 2019 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Apr 5, 2019 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 5, 2019 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Apr 4, 2019 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Apr 4, 2019 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Apr 4, 2019 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Mar 26, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 26, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 14, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 14, 2018 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 14, 2018 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 14, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 11, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 20, 2018 | AMPX | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | — |
| Aug 16, 2018 | ALIE | ASSIGNED TO LIE | — |
| Jul 29, 2018 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| May 30, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 24, 2018 | NWAP | NEW APPLICATION ENTERED | — |